Concepedia

Talal Widatalla

TW

Statistics

Publications

4

Citations

106

H-Index

4

Active since

2023

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Stanford University

Talal Widatalla is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in machine learning feature engineering, bioinformatics, and computational developability prediction.

ORCID

Publications per year

2023–2025

4

Publications

4

A machine learning strategy for the identification of key <i>in silico</i> descriptors and prediction models for IgG monoclonal antibody developability properties

Andrew B. Waight, David Příhoda, Rojan Shrestha et al. · mAbs · 2023 · 41 citations · Full text

, , +17

Aligning protein generative models with experimental fitness via Direct Preference Optimization

Talal Widatalla, Rafael Rafailov, Brian Hie · bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 32 citations · Full text

, , +8

Efficient generation of epitope-targeted <i>de novo</i> antibodies with Germinal

Luis Santiago Mille, Talal Widatalla, Brian Hie et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2025 · 22 citations · Full text

, , +17

AbMelt: Learning antibody thermostability from molecular dynamics

Zachary A. Rollins, Talal Widatalla, Alan C. Cheng et al. · Biophysical Journal · 2024 · 11 citations · Full text

, , +14

1–4 of 4